Gabelli Funds’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.3M | Sell |
508,600
-67,900
| -12% | -$1.81M | 0.1% | 257 |
|
|
2025
Q4 | $14.4M | Sell |
576,500
-9,900
| -2% | -$250K | 0.1% | 254 |
|
|
2025
Q3 | $14.9M | Buy |
586,400
+12,900
| +2% | +$318K | 0.1% | 249 |
|
|
2025
Q2 | $13.9M | Sell |
573,500
-467,425
| -45% | -$10.9M | 0.1% | 256 |
|
|
2025
Q1 | $26.4M | Buy |
1,040,925
+11,200
| +1% | +$293K | 0.2% | 128 |
|
|
2024
Q4 | $27.3M | Buy |
1,029,725
+23,375
| +2% | +$634K | 0.21% | 134 |
|
|
2024
Q3 | $29.1M | Buy |
1,006,350
+264,237
| +36% | +$7.71M | 0.21% | 128 |
|
|
2024
Q2 | $20.8M | Buy |
742,113
+31,700
| +4% | +$873K | 0.16% | 175 |
|
|
2024
Q1 | $19.7M | Buy |
710,413
+133,200
| +23% | +$3.7M | 0.15% | 195 |
|
|
2023
Q4 | $16.6M | Sell |
577,213
-22,700
| -4% | -$686K | 0.13% | 210 |
|
|
2023
Q3 | $19.9M | Sell |
599,913
-2,800
| -0.5% | -$99K | 0.16% | 181 |
|
|
2023
Q2 | $22.1M | Buy |
602,713
+650
| +0.1% | +$25.3K | 0.17% | 172 |
|
|
2023
Q1 | $24.6M | Buy |
602,063
+4,650
| +0.8% | +$201K | 0.19% | 154 |
|
|
2022
Q4 | $30.6M | Sell |
597,413
-150
| -0% | -$7.19K | 0.24% | 113 |
|
|
2022
Q3 | $26.1M | Sell |
597,563
-4,800
| -0.8% | -$233K | 0.22% | 129 |
|
|
2022
Q2 | $31.6M | Buy |
602,363
+4,850
| +0.8% | +$247K | 0.24% | 112 |
|
|
2022
Q1 | $30.9M | Sell |
597,513
-1,700
| -0.3% | -$88.2K | 0.2% | 132 |
|
|
2021
Q4 | $35.4M | Sell |
599,213
-23,000
| -4% | -$1.14M | 0.22% | 124 |
|
|
2021
Q3 | $26.8M | Buy |
622,213
+93,125
| +18% | +$4.13M | 0.18% | 151 |
|
|
2021
Q2 | $20.7M | Sell |
529,088
-4,500
| -0.8% | -$175K | 0.13% | 210 |
|
|
2021
Q1 | $19.3M | Sell |
533,588
-4,000
| -0.7% | -$142K | 0.13% | 209 |
|
|
2020
Q4 | $19.8M | Sell |
537,588
-31,138
| -5% | -$1.14M | 0.14% | 188 |
|
|
2020
Q3 | $19.8M | Sell |
568,726
-6,324
| -1% | -$222K | 0.15% | 171 |
|
|
2020
Q2 | $17.8M | Sell |
575,050
-157,189
| -21% | -$5.34M | 0.15% | 184 |
|
|
2020
Q1 | $22.7M | Buy |
732,239
+8,432
| +1% | +$287K | 0.2% | 139 |
|
|
2019
Q4 | $26.9M | Buy |
723,807
+14,756
| +2% | +$526K | 0.17% | 167 |
|
|
2019
Q3 | $24.2M | Sell |
709,051
-15,810
| -2% | -$575K | 0.16% | 183 |
|
|
2019
Q2 | $29.8M | Sell |
724,861
-25,296
| -3% | -$1M | 0.19% | 152 |
|
|
2019
Q1 | $30.2M | Sell |
750,157
-41,633
| -5% | -$1.67M | 0.19% | 157 |
|
|
2018
Q4 | $32.8M | Sell |
791,790
-195,201
| -20% | -$8.1M | 0.22% | 125 |
|
|
2018
Q3 | $41.3M | Sell |
986,991
-47,430
| -5% | -$1.83M | 0.24% | 123 |
|
|
2018
Q2 | $35.6M | Sell |
1,034,421
-78,312
| -7% | -$2.68M | 0.21% | 141 |
|
|
2018
Q1 | $37.5M | Sell |
1,112,733
-3,689
| -0.3% | -$127K | 0.22% | 134 |
|
|
2017
Q4 | $38.4M | Sell |
1,116,422
-192,170
| -15% | -$6.55M | 0.22% | 129 |
|
|
2017
Q3 | $44.3M | Buy |
1,308,592
+153,884
| +13% | +$4.95M | 0.25% | 115 |
|
|
2017
Q2 | $36.8M | Sell |
1,154,708
-33,728
| -3% | -$1.06M | 0.22% | 138 |
|
|
2017
Q1 | $38.6M | Buy |
1,188,436
+19,420
| +2% | +$612K | 0.23% | 131 |
|
|
2016
Q4 | $36M | Sell |
1,169,016
-75,888
| -6% | -$2.32M | 0.21% | 146 |
|
|
2016
Q3 | $40M | Sell |
1,244,904
-158,100
| -11% | -$5.29M | 0.24% | 125 |
|
|
2016
Q2 | $46.9M | Sell |
1,403,004
-391,034
| -22% | -$12.5M | 0.28% | 98 |
|
|
2016
Q1 | $50.5M | Sell |
1,794,038
-228,718
| -11% | -$6.53M | 0.3% | 94 |
|
|
2015
Q4 | $61.9M | Buy |
2,022,756
+42,160
| +2% | +$1.33M | 0.38% | 65 |
|
|
2015
Q3 | $59M | Hold |
1,980,596
| – | – | 0.35% | 75 |
|
|
2015
Q2 | $63M | Sell |
1,980,596
-52,700
| -3% | -$1.72M | 0.33% | 84 |
|
|
2015
Q1 | $67.1M | Sell |
2,033,296
-147,560
| -7% | -$4.69M | 0.34% | 81 |
|
|
2014
Q4 | $64.5M | Sell |
2,180,856
-189,720
| -8% | -$5.44M | 0.31% | 92 |
|
|
2014
Q3 | $66.5M | Sell |
2,370,576
-47,171
| -2% | -$1.32M | 0.34% | 83 |
|
|
2014
Q2 | $68.1M | Buy |
2,417,747
+85,795
| +4% | +$2.45M | 0.34% | 85 |
|
|
2014
Q1 | $71.1M | Sell |
2,331,952
-29,512
| -1% | -$880K | 0.37% | 70 |
|
|
2013
Q4 | $68.6M | Buy |
2,361,464
+15,810
| +0.7% | +$460K | 0.37% | 67 |
|
|
2013
Q3 | $63.9M | Sell |
2,345,654
-1,475
| -0.1% | -$40.1K | 0.36% | 70 |
|
|
2013
Q2 | $62.4M | Buy |
+2,347,129
| New | +$64.9M | 0.38% | 64 |
|
Other funds holding PFE
VCM
VPM
Gabelli Funds's PFE Position: Q1 2026 in Review
Gabelli Funds reduced its Pfizer (PFE) stake by 12% in Q1 2026, selling an estimated $1.81M and leaving 508,600 shares worth $14.3M. The position accounts for 0.1% of the portfolio, ranked #257.
Gabelli Funds first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $71.1M in Q1 2014. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Gabelli Funds held 508,600 shares of Pfizer worth $14.3M as of Q1 2026.
- Gabelli Funds sold 67,900 Pfizer shares in Q1 2026, an estimated $1.81M.
- Pfizer made up 0.1% of Gabelli Funds's portfolio in Q1 2026, its #257 holding.
- Gabelli Funds first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Gabelli Funds's Pfizer position peaked at $71.1M in Q1 2014.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.